Slide 1
Our Company

Mission Statement

Stimdia Medical is dedicated to developing innovative medical technologies that expedite ventilator weaning and patient liberation.

Company Background

Stimdia Medical Inc. was founded in September 2015 out of the University of Minnesota and is located in the Minneapolis area. The company has received funding from a prestigious group of investors which includes Solas BioVentures, Draper Triangle Ventures, University of Minnesota Discovery Capital Fund, Piedmont Capital Partners, and two strategic partners.

Our Leadership Team

Stimdia Medical’s leadership team possesses deep expertise in the development, clinical research, and commercialization of innovative medical device technologies, with a particular focus on neuromodulation.  With experience spanning both large multinational corporations and emerging growth companies, they bring a well-rounded perspective on the industry’s challenges and opportunities.  Driven by a shared vision, they are excited to collaborate and create meaningful value at Stimdia.

Allen Meacham

President and Chief Executive Officer

Link to bio

Kristen Lechleiter

Vice President of Clinical and Regulatory Affairs

Link to bio

Matt McDonald

Vice President of Research and Development

Link to bio

Board of Directors

Stimdia Medical’s Board of Directors consists of world-class investors and champions from the medical device industry who support the company’s vision and mission.

Jim Bullock

Board Chair

Link to bio

David Adair, MD, MBA

Director, Solas Bioventures

Link to bio

Jay Katarincic, JD/MSIA

Director, Draper Triangle Ventures

Link to bio

Albert Wiegman, MBA

Director, Fresenius Medical Care

Link to bio

Allen Meacham

President and Chief Executive Officer, Stimdia Medical

Link to bio

Strategic Advisors

In addition to having a proven leadership team, Stimdia Medical has engaged world-class leaders in product development, quality systems and regulatory strategy with the relevant experience and expertise required to support development of the pdSTIM System.

 

Bruce Johnson, PhD
Professor of Medicine and Physiology
Mayo Clinic
Rochester, MN USA

Amal Jubran, MD
Pulmonary and Critical Care Medicine Professor
Loyola University Medical Center
Maywood, IL USA

Tariq Janjua, MD
Critical Care and Neurointensivist
Regions Hospital
St. Paul, MN USA

Marco Ranieri, M.D.
Chairman, Department of Anesthesia and Critical Care Medicine
Azienda Ospedaliera Policlinico Umberto
Professor of Anesthesia and Intensive Care
University of Rome
Rome, Italy

Steven Conrad, MD, PhD, MBA, MCCM, FACP, FCCP, FACEP, FAAEM, FELSO
Critical Care Medicine and Emergency Medicine
Louisiana State University Health Sciences Center
Shreveport, LA USA

ReInvigorate Study National Principal Investigator

James O’Rourke, M.B.*
Anaesthesia and Intensive Care Medicine
Royal College of Surgeons in Ireland (RCSI) in Beaumont Hospital
Dublin, Ireland

Michal Soták, M.D.*
Department of Anesthesia and Intensive Medicine
First Medical Faculty, Charles University and University Military Hospital
Prague, Czech Republic

 

*Clinical Investigator for Stimdia’s PEPNS Study

Careers

Stimdia Medical is committed to developing medical technologies which improve patient care and quality of life. The company is committed to achieving success in a highly entrepreneurial environment. 

Contact us if you believe you have the background and experience to support our efforts.